Your email has been successfully added to our mailing list.

×
0.0011894350183663 0.00402308903270941 0.000524750743396906 0.00752142732202207 -0.00997026412454091 -0.0169669407031661 -0.004722756690572 0.0145181039006472
Stock impact report

Axovant's Parkinson's Gene Therapy Is Extremely Risky [Seeking Alpha]

Axon Enterprise, Inc. (AXON) 
Last axon enterprise, inc. earnings: 2/7 04:15 pm Check Earnings Report
Company Research Source: Seeking Alpha
Summary Insanity: doing the same thing over and over again and expecting different results.” Albert Einstein The company Axovant Sciences ( AXON ) debuted in June 2015. The initial public offering raised $315 million. The stock climbed $14.90, or 99.3 percent to end its first trading day at $29.90. The offering valued Axovant at around $1.4 billion; it currently has a market capitalization of approximately $400 million. The company's majority shareholder, Roivant Sciences Ltd. (a non-public company), is led by Vivek Ramaswamy. Roivant licenses or purchases drugs from other companies that appear to have achieved some statistical significance, then sells these drugs to Axovant for further clinical development. Axovant has no basic research and development of its own. To date, Axovant has entered two drugs into trials and failed. Axovant has now pivoted to central nervous system gene therapy with a product whose initial clinical results couldn't be differentiat Show less Read more
Impact Snapshot
Event Time:
AXON
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for AXON alerts
Opt-in for
AXON alerts

from News Quantified
Opt-in for
AXON alerts

from News Quantified